Literature DB >> 3495998

Potential contrast agents for MR arthrography: in vitro evaluation and practical observations.

P C Hajek, D J Sartoris, C H Neumann, D Resnick.   

Abstract

In an attempt to identify an ideal contrast agent for MR arthrography, signal behavior as well as T1 and T2 values for articular cartilage, menisci, and ligaments were determined in knees from cadavers and normal volunteers. Comparison was made with similar data derived for intraarticular blood, varying concentrations of an albumin-saline solution (simulating synovial fluid) and Gd-DTPA, 0.9% saline, Renografin 60%, and air. Cadaveric specimens were imaged after intraarticular administration of each substance. A 500-microM volume of Gd-DTPA proved to be an ideal contrast agent for MR arthrography, exhibiting excellent contrast differences with articular structures on T1-weighted images. An albumin concentration of 12%, potentially occurring in severe inflammatory arthritis, also manifested adequate contrast to articular cartilage on T1-weighted images. Renografin and saline provided inadequate contrast on T1-weighted images, and saline necessitated the use of T2-weighted sequences. Air was not found to be an optimal contrast agent. Intraarticular blood exhibited insufficient contrast differences with articular cartilage during the acute hemorrhagic phase. Synovial fluid associated with severe arthritis as compared with fresh intraarticular hemorrhage may thus prove to be a better biological contrast agent for MR arthrography. Saline is currently recommended for use in arthrography, but Gd-DTPA offers significant advantages and should be safety-tested for potential clinical use.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3495998     DOI: 10.2214/ajr.149.1.97

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  9 in total

Review 1.  Direct magnetic resonance arthrography.

Authors:  Dmitry Elentuck; William E Palmer
Journal:  Eur Radiol       Date:  2004-09-03       Impact factor: 5.315

Review 2.  Technical errors in MR arthrography.

Authors:  Juerg Hodler
Journal:  Skeletal Radiol       Date:  2007-05-26       Impact factor: 2.199

3.  Unclassified MR arthrography pattern evaluation in patients with episodes of recurrent antero-inferior shoulder dislocation.

Authors:  Luca Saba; Massimo De Filippo
Journal:  Radiol Med       Date:  2017-03-17       Impact factor: 3.469

4.  Incidence of gadolinium or fluid signal within surgically proven glenoid labral tears at MR arthrography.

Authors:  Nicholas C Nacey; Michael G Fox; Christopher J Bertozzi; Jennifer L Pierce; Nicholas Said; David R Diduch
Journal:  Skeletal Radiol       Date:  2019-01-25       Impact factor: 2.199

Review 5.  Imaging of shoulder instability.

Authors:  Massimo De Filippo; Silvia Schirò; Dani Sarohia; Antonio Barile; Luca Saba; Simone Cella; Alessandro Castagna
Journal:  Skeletal Radiol       Date:  2020-05-23       Impact factor: 2.199

6.  A comparison of saline and gadolinium shoulder MR arthrography to arthroscopy.

Authors:  Adam D Singer; Jeffrey Rosenthal; Monica Umpierrez; Yi Guo; Felix Gonzalez; Eric Wagner
Journal:  Skeletal Radiol       Date:  2019-11-27       Impact factor: 2.199

Review 7.  Magnetic resonance imaging of the knee: current status, new directions.

Authors:  P L Munk; C A Helms; H K Genant; R G Holt
Journal:  Skeletal Radiol       Date:  1989       Impact factor: 2.199

8.  MRI of the knee joint with a 3-D gradient echo sequence. Equivalent to diagnostic arthroscopy?

Authors:  K Glückert; B Kladny; A Blank-Schäl; G Hofmann
Journal:  Arch Orthop Trauma Surg       Date:  1992       Impact factor: 3.067

9.  Effects of iodinated contrast agent, xylocaine and gadolinium concentration on the signal emitted in magnetic resonance arthrography: a samples study.

Authors:  Yvana Lopes Pinheiro da Silva; Rita Zanlorensi Visneck Costa; Kátia Elisa Prus Pinho; Ricardo Rabello Ferreira; Sueliton Miyamoto Schuindt
Journal:  Radiol Bras       Date:  2015 Mar-Apr
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.